Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions

Abstract

The present study demonstrates that maintained lipid-lowering therapy with simvastatin is associated with significant regression of established atherosclerotic lesions in humans. Our observations indicate that lipid-lowering therapy is associated with sustained vascular remodeling and emphasize the need for longer-term treatment.